Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 634c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of $6.03, $6.34 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $37.14 million versus the consensus estimate of $32.41 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Roivant Sciences (ROIV) Reiterated at Overweight by Cantor Fitzgerald: 'Thesis Unchanged'
• Nvidia Q2 preview: a beat is a fail, a blowout is base case
• Rush Enterprises Inc. (RUSHA) PT Raised to $85 at UBS